share_log

Cellcom Israel Ltd. (OTCMKTS:CELJF) Sees Significant Growth in Short Interest

Financial News Live ·  12/15/2022 00:51

Cellcom Israel Ltd. (OTCMKTS:CELJF – Get Rating) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 91,800 shares, an increase of 41.4% from the November 15th total of 64,900 shares. Based on an average daily volume of 1,400 shares, the days-to-cover ratio is presently 65.6 days.

Cellcom Israel Stock Performance

Shares of OTCMKTS:CELJF traded up $0.91 during mid-day trading on Wednesday, hitting $5.25. 3,503 shares of the company traded hands, compared to its average volume of 1,656. The firm's 50 day simple moving average is $4.99 and its 200 day simple moving average is $5.21. Cellcom Israel has a 52-week low of $3.93 and a 52-week high of $6.37. The firm has a market cap of $857.53 million, a P/E ratio of -47.70 and a beta of 0.88.

Get Cellcom Israel alerts:

Cellcom Israel Company Profile

(Get Rating)

Cellcom Israel Ltd. provides cellular communications services in Israel. It operates in two segments, Real Estate and Net. The company offers internet access and infrastructure, internet television, international telephony, landline telephony, and transmission services for business customers and telecommunications operators.

Further Reading

  • Get a free copy of the StockNews.com research report on Cellcom Israel (CELJF)
  • REV Group Leads Specialty Vehicle Manufacturers Higher
  • NVIDIA vs AMD: Which is better for 2023?
  • Will Nordstrom Stock be the Grinch This Year?
  • Harpoon Therapeutics Remains Volatile After Promising News
  • We Are the Champions: 3 Dividend Growers Wall Street Loves

Receive News & Ratings for Cellcom Israel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellcom Israel and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment